DK1404641T3 - Krystallinsk form af en phenylethanolarmin, fremstilling herfra og farmaceutiske præparater, der indeholder den - Google Patents

Krystallinsk form af en phenylethanolarmin, fremstilling herfra og farmaceutiske præparater, der indeholder den

Info

Publication number
DK1404641T3
DK1404641T3 DK02780917T DK02780917T DK1404641T3 DK 1404641 T3 DK1404641 T3 DK 1404641T3 DK 02780917 T DK02780917 T DK 02780917T DK 02780917 T DK02780917 T DK 02780917T DK 1404641 T3 DK1404641 T3 DK 1404641T3
Authority
DK
Denmark
Prior art keywords
phenylethanolarmine
preparation
crystalline form
pharmaceutical preparations
preparations containing
Prior art date
Application number
DK02780917T
Other languages
English (en)
Inventor
Sabrina Obert
Jerome Roche
Isabelle Ziri
Antoine Caron
Olivier Monnier
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK1404641T3 publication Critical patent/DK1404641T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
DK02780917T 2001-06-28 2002-06-27 Krystallinsk form af en phenylethanolarmin, fremstilling herfra og farmaceutiske præparater, der indeholder den DK1404641T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0108562A FR2826651B1 (fr) 2001-06-28 2001-06-28 Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
PCT/FR2002/002235 WO2003002510A1 (fr) 2001-06-28 2002-06-27 Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant

Publications (1)

Publication Number Publication Date
DK1404641T3 true DK1404641T3 (da) 2008-12-08

Family

ID=8864888

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02780917T DK1404641T3 (da) 2001-06-28 2002-06-27 Krystallinsk form af en phenylethanolarmin, fremstilling herfra og farmaceutiske præparater, der indeholder den

Country Status (30)

Country Link
US (1) US6992211B2 (da)
EP (1) EP1404641B1 (da)
JP (2) JP4171413B2 (da)
KR (1) KR100869017B1 (da)
CN (1) CN1269797C (da)
AR (1) AR034648A1 (da)
AT (1) ATE403642T1 (da)
AU (1) AU2002333942B2 (da)
BR (1) BR0210661A (da)
CA (1) CA2450213C (da)
CY (1) CY1110099T1 (da)
CZ (1) CZ301450B6 (da)
DE (1) DE60228088D1 (da)
DK (1) DK1404641T3 (da)
EE (1) EE05380B1 (da)
ES (1) ES2307798T3 (da)
FR (1) FR2826651B1 (da)
HK (1) HK1063621A1 (da)
HU (1) HUP0401229A3 (da)
IL (2) IL159134A0 (da)
MX (1) MXPA03011742A (da)
NO (1) NO331169B1 (da)
NZ (1) NZ530140A (da)
PL (1) PL206680B1 (da)
PT (1) PT1404641E (da)
SI (1) SI1404641T1 (da)
SK (1) SK287355B6 (da)
TW (1) TWI286129B (da)
WO (1) WO2003002510A1 (da)
ZA (1) ZA200309512B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826651B1 (fr) * 2001-06-28 2005-09-02 Sanofi Synthelabo Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
EP1623705A1 (en) * 2004-07-09 2006-02-08 Sanofi-Aventis Use of phenylethanolaminotetralines for preparing anxiolytic drugs
FR2890862B1 (fr) * 2005-09-19 2008-01-25 Sanofi Aventis Sa Association d'agoniste aux recepteurs beta 3 et d'inhibiteur de la recapture de monoamnies, compostion pharmaceutique la contenant et son utilisation en therapeutique.
EP3397765B1 (en) 2015-12-30 2023-02-01 Bio-Rad Laboratories, Inc. Method for quantitating the frequency of wild-type and mutant fragments in a nucleic acid sample

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3852589T2 (de) * 1987-08-12 1995-08-10 Sanofi Sa Verfahren zur O-Alkylierung von N-(Hydroxy)aralkylphenylethanolamin.
US5198586A (en) * 1987-08-12 1993-03-30 Sanofi Process for the preparation of phenylethanolaminotetralins
US5235103A (en) * 1987-08-12 1993-08-10 Sanofi Process for the preparation of phenylethanolaminotetralins
US5202466A (en) * 1988-06-14 1993-04-13 Sanofi 2-amino-7-hydroxytetraline ethers
FR2643076B1 (fr) * 1989-02-14 1991-06-21 Midy Spa Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
FR2648042B1 (fr) * 1989-06-13 1994-06-10 Midy Spa Utilisation de phenylethanolaminotetralines pour la preparation de medicaments pour le traitement des affections oculaires
US5312961A (en) * 1989-02-14 1994-05-17 Elf Sanofi 2-amino-7-hydroxytetralin carboxylalkyl ethers
FR2669821A1 (fr) * 1990-12-04 1992-06-05 Sanofi Sa Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression.
FR2826651B1 (fr) * 2001-06-28 2005-09-02 Sanofi Synthelabo Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant

Also Published As

Publication number Publication date
JP2004530725A (ja) 2004-10-07
EP1404641A1 (fr) 2004-04-07
PL206680B1 (pl) 2010-09-30
ATE403642T1 (de) 2008-08-15
KR100869017B1 (ko) 2008-11-17
WO2003002510A1 (fr) 2003-01-09
PT1404641E (pt) 2008-09-22
CN1269797C (zh) 2006-08-16
MXPA03011742A (es) 2004-07-01
HUP0401229A3 (en) 2008-03-28
SK15932003A3 (sk) 2004-05-04
BR0210661A (pt) 2004-10-05
HK1063621A1 (en) 2005-01-07
TWI286129B (en) 2007-09-01
EE200400007A (et) 2004-02-16
AR034648A1 (es) 2004-03-03
SI1404641T1 (sl) 2008-10-31
IL159134A0 (en) 2004-05-12
ES2307798T3 (es) 2008-12-01
HUP0401229A2 (hu) 2004-10-28
NO331169B1 (no) 2011-10-24
JP4799592B2 (ja) 2011-10-26
ZA200309512B (en) 2004-12-08
NZ530140A (en) 2005-05-27
JP2009029804A (ja) 2009-02-12
CZ20033531A3 (en) 2004-04-14
CA2450213A1 (en) 2003-01-09
CN1522241A (zh) 2004-08-18
FR2826651B1 (fr) 2005-09-02
IL159134A (en) 2009-07-20
SK287355B6 (sk) 2010-08-09
CA2450213C (en) 2011-02-15
NO20035839L (no) 2004-03-01
KR20040017817A (ko) 2004-02-27
US20040180953A1 (en) 2004-09-16
AU2002333942B2 (en) 2008-02-28
EE05380B1 (et) 2011-02-15
EP1404641B1 (fr) 2008-08-06
PL368055A1 (en) 2005-03-21
JP4171413B2 (ja) 2008-10-22
CY1110099T1 (el) 2015-01-14
CZ301450B6 (cs) 2010-03-03
FR2826651A1 (fr) 2003-01-03
DE60228088D1 (de) 2008-09-18
US6992211B2 (en) 2006-01-31

Similar Documents

Publication Publication Date Title
NO20024175L (no) Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
DK1417206T3 (da) Hidtil ukendte 2H-pyridazin-3-on-derivater, farmaceutiske præparater indeholdende det samme, og en fremgangsmåde til fremstilling af den aktive bestanddel
DK1478339T3 (da) Farmaceutiske formuleringer af antineoplastiske midler, specielt temozolomid, fremgangsmåder til fremstilling og anvendelse heraf
IS6957A (is) Tatrat sölt af 5,8,14,-tríasatetrasýkló[10.3.1.02,11.04,9]-hexadeka-2(11),3,5,7,9,-pentaen og lyfjafræðilegar samsetningar af þeim
NO20032438L (no) Ortosubstituerte og metasubstituerte bisarylforbindelser, fremgangsmåte forfremstilling derav, deres anvendelse som et medikament samtfarmasöytiske preparater inneholdende forbindelsene
DK1263721T3 (da) Farmaceutiske sammensætninger, der indeholder 3-aminoazetidinderivater, nye derivater og fremstilling deraf
NO20033556D0 (no) Farmasöytiske preparater
DK1401445T3 (da) Krystallinsk anticholinergikum, fremgangsmåde til fremstilling af dette og anvendelse af dette til fremstilling af et lægemiddel
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20035298D0 (no) CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler
PT1207867E (pt) Formas de administracao farmaceuticas orais retardadas contendo tramadol
NO20071303L (no) Farmasoytiske preparater
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
ATE296619T1 (de) Feste orale dosierungsform von simethicon
DK1337529T3 (da) Heterocyclylalkylpiperidinderivater, deres fremstilling og præparater indeholdende dem
DK200300346U1 (da) Farmaceutiske præparat indeholdende amlodipinmaleat
DK1414816T3 (da) Stabil polymorf af flibanserin, teknisk fremgangsmåde til fremstilling deraf og anvendelse deraf til lægemiddelfremstilling
DK200300344U4 (da) Farmaceutisk præparat indeholdende amlodipinmaleat
DK1370550T3 (da) Quinolylpropylpiperidinderivater, deres fremstilling og præparater indeholdende dem
DK1411923T3 (da) Farmaceutisk sammensætning af amlodipin og atorvastatin
DK1322158T3 (da) Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
DK1230230T3 (da) Derivater af indeno-dihydrothiazol, fremstilling deraf og anvendelse som anorektiske lægemidler
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
IS6956A (is) Sítrat salt af 5,8,14,-tríasatetrasýkló[10.3.1.02,11.04,9]-hexadeka-2(11),3,5,7,9-pentaen og lyfjafræðilegar samsetningar af því
DK1425005T3 (da) Farmaceutisk sammensætning indeholdende lumiracoxib